The Icelandic biotech company Alvotech has spent 180 billion kroner since its founding developing new pharmaceutical equivalents to medicines. The company has existed for 10 years. “To put this amount into perspective, it is roughly equivalent to the cost of building two new Landspítals. We are developing eight drugs and have secured access to more than 90 markets around the world.” […]
Article 180 billion for the development of pharmacology comes from ICELAND NEWS.
Source: Yle